Generation Bio Co.
GBIO
$6.35
$0.223.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -81.30% | 114.91% | 45.52% | 252.00% | 364.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -81.30% | 114.91% | 45.52% | 252.00% | 364.89% |
| Cost of Revenue | -6.73% | 8.72% | -43.44% | -35.65% | -29.46% |
| Gross Profit | -27.86% | 55.18% | 57.13% | 73.57% | 49.38% |
| SG&A Expenses | -13.70% | -10.85% | -37.51% | -17.67% | -21.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.22% | -2.31% | -40.60% | -27.56% | -25.85% |
| Operating Income | -3.18% | 25.29% | 47.05% | 46.69% | 35.99% |
| Income Before Tax | -2.40% | 80.14% | 39.23% | 45.83% | 34.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.40% | 80.14% | 39.23% | 45.83% | 34.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.40% | 80.14% | 39.23% | 45.83% | 34.23% |
| EBIT | -3.18% | 25.29% | 47.05% | 46.69% | 35.99% |
| EBITDA | -4.01% | 26.09% | 48.33% | 48.33% | 37.28% |
| EPS Basic | -1.63% | 80.31% | 39.90% | 46.50% | 35.10% |
| Normalized Basic EPS | -7.54% | 23.07% | 48.95% | 50.58% | 40.17% |
| EPS Diluted | -1.63% | 80.31% | 39.90% | 46.50% | 35.10% |
| Normalized Diluted EPS | -7.54% | 23.07% | 48.95% | 50.58% | 40.17% |
| Average Basic Shares Outstanding | 0.76% | 0.86% | 1.10% | 1.26% | 1.33% |
| Average Diluted Shares Outstanding | 0.76% | 0.86% | 1.10% | 1.26% | 1.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |